These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9207629)

  • 1. Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
    Kuga T; Mohri M; Egashira K; Hirakawa Y; Tagawa T; Shimokawa H; Takeshita A
    J Am Coll Cardiol; 1997 Jul; 30(1):108-12. PubMed ID: 9207629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
    Prasad A; Husain S; Quyyumi AA
    J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
    Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
    J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy.
    Mohri M; Tagawa H; Egashira K; Takeshita A
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):249-55. PubMed ID: 10672857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
    Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M; Shiode N; Teragawa H; Hirao H; Yamada T; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans.
    Prasad A; Husain S; Schenke W; Mincemoyer R; Epstein N; Quyyumi AA
    J Am Coll Cardiol; 2000 Nov; 36(5):1467-73. PubMed ID: 11079644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
    Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
    J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
    Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
    Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
    Li P; Chappell MC; Ferrario CM; Brosnihan KB
    Hypertension; 1997 Jan; 29(1 Pt 2):394-400. PubMed ID: 9039133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo.
    Nishikawa Y; Stepp DW; Chilian WM
    Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H459-65. PubMed ID: 10924042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of nitric oxide in the coronary artery at rest and during pacing in humans.
    Nishikawa Y; Ogawa S
    J Am Coll Cardiol; 1997 Jan; 29(1):85-92. PubMed ID: 8996299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans.
    Egashira K; Katsuda Y; Mohri M; Kuga T; Tagawa T; Kubota T; Hirakawa Y; Takeshita A
    Circ Res; 1996 Aug; 79(2):331-5. PubMed ID: 8756012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
    Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
    Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide activity in the atherosclerotic human coronary circulation.
    Quyyumi AA; Dakak N; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO
    J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
    Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
    Nakamura M; Funakoshi T; Arakawa N; Yoshida H; Makita S; Hiramori K
    J Am Coll Cardiol; 1994 Nov; 24(5):1321-7. PubMed ID: 7930256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
    Hornig B; Arakawa N; Haussmann D; Drexler H
    Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
    Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
    Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.